News
SleepioRx

US insomniacs have a new prescription DTx option

It is estimated that around one in four US adults suffer from insomnia, raising their risk of other health conditions, and the recent approval of a digital therapeutic gives them a treatmen

Debates

News

Press Releases

Newsletters and Deep Dive
digital magazine

Views & Analysis

Digital
12 Questions with Sam Dixey
Sponsored

12 Questions with Sam Dixey

Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content